Navigation Links
New Colon Cancer Screening Guidelines Focus on Individual Risk
Date:3/6/2012

By Carina Storrs
HealthDay Reporter

MONDAY, March 5 (HealthDay News) -- New guidelines for colorectal cancer screening from the American College of Physicians (ACP) put the emphasis on individual risk.

People at average risk of developing colorectal cancer should get screened starting at age 50, whereas people at high risk -- those with inflammatory bowel disease or a personal or family history of the disease -- should get screened starting at age 40 or earlier, according to the updated recommendations. The guidelines appear in the March 6 issue of the Annals of Internal Medicine. March is U.S. National Colorectal Cancer Awareness Month.

In arriving at the new guidelines, the ACP evaluated the quality of colorectal cancer screening guidelines from many medical organizations to develop a "take-home message" both to help physicians make decisions and to help patients discuss screenings with their doctor, explained Dr. Amir Qaseem, director of clinical policy for the ACP and lead author of the guidelines.

"I think we are recommending something that the majority of organizations do: a risk assessment of people to see if they need to be screened earlier than 50 and for doctors to talk about the options," Qaseem said.

The guidelines recommend several screening options for average-risk patients: optical colonoscopy or flexible sigmoidoscopy, both of which involve inserting a narrow tube with a camera into the rectum, or stool sample tests.

All of these tests are thought to be similarly effective at preventing colorectal cancer-related death for average-risk patients, so the ACP decided that the choice of which to use should come down to factors such as patients' personal preferences and how well they are expected to tolerate the tests.

"Each has their benefits and harms," Qaseem said. The risk of bleeding and puncture of the colon may be higher in certain patients with invasive tests like optical colonoscopy and flexible sigmoidoscopy.

High-risk patients, on the other hand, should have an optical colonoscopy, which is the most sensitive test and the only one of the recommended tests that examines the entire colon.

Colorectal cancer is the second leading cause of cancer-related deaths in the United States. Although screening can prevent deaths, only about 60 percent of adults aged 50 years and older in the United States get screened.

The fact that patients have many screening tests from which to choose will hopefully allow them to find one with which they are comfortable, Qaseem said.

"The ACP did a good service in developing a consensus guideline," said Dr. Frank Sinicrope, a professor of medicine and oncology at the Mayo Clinic in Rochester, Minn. "It's one source that internists and other physicians can go to."

Although other guidelines have included the importance of individual risk assessment, not all of them have embraced it, Sinicrope added. "We like to figure out who is average risk -- most of the patients -- and make a recommendation for them," he said. "[We] also consider higher risk [patients] who need a different recommendation."

People with a first-degree relative (parents, siblings, or children) who was diagnosed with colorectal cancer are at increased risk, and should start getting screened either at age 40 or 10 years before the age at which their relative was diagnosed, whichever comes first, according to the guidelines. Black people could also be at increased risk of developing colorectal cancer.

Getting a patient's family history is important for doctors to remember to do, Sinicrope said. "Family history data is elicited less frequently and is really not as detailed to do this properly," he said.

The guidelines also advise against screening people who are over 75 years old or who have a life expectancy of less than 10 more years because they are more likely to die of causes other than colorectal cancer, which takes a while to progress.

This is another instance where each patient should be assessed individually, however. "Some people at 75 may be healthier than some at 55, and you have to make a clinical judgment," Qaseem said. "In those patients it may be OK [to screen], because they may be living to 100."

The decision of which screening test to use also depends on what doctors feel comfortable with, Sinicrope said.

Although there is evidence to support using a newer form of noninvasive colonoscopy, called CT or virtual, colonoscopy, Sinicrope said there are not enough doctors who have expertise with the technology for it to be reliable. The ACP guidelines did not recommend CT colonoscopy.

In all, the ACP panel reviewed guidelines from five organizations that each focused on different aspects of screening: the U.S. Preventive Services Task Force, the Institute for Clinical Systems Improvement, the American College of Radiology, the American College of Gastroenterology, and the joint guidelines by the American Cancer Society, the U.S. Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.

More information

Find out more about colon cancer at the American Cancer Society.

SOURCES: Amir Qaseem, M.D., director, clinical policy, American College of Physicians; Frank Sinicrope, M.D., professor, medicine and oncology, Mayo Clinic, Rochester, Minn.; March 6, 2012, Annals of Internal Medicine


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S.
2. New SeaColonyTennis.net Launches to Promote World-Class Tennis Programs at Sea Colony
3. President Obama Gets Virtual Colonoscopy (CT Colonography) But Medicare Denies CTC Coverage to Seniors
4. Proteins May Predict Spread of Colon Cancer
5. Obese Colon Cancer Survivors Face Poorer Prognosis
6. Obesity linked to poor colon cancer prognosis
7. Study evaluates costs and benefits associated with new colon cancer therapies
8. Older Colon Cancer Patients Less Likely to Get Chemo
9. Colonoscopy Not Needed for Most With Irritable Bowel Syndrome
10. Studies examine Third Eye Retroscope during colonoscopy
11. Virtual colonoscopy allows detection of unsuspected cancers beyond colon
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Colon Cancer Screening Guidelines Focus on Individual Risk
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice ... X users can now reveal the media of their split screens with growing ...
(Date:6/26/2016)... (PRWEB) , ... June 27, 2016 , ... Quality metrics ... yet in many ways they remain in the eye of the beholder, according to ... a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
Breaking Medicine Technology: